From medicine to business and wellness
Effective May 1, 2022, Magellan Rx Management will include dosage considerations when performing prior authorization/medical necessity determination reviews of several infused drug products that are to be provided to members enrolled in fully insured plans.
Subscribe to get the latest posts sent to your email.
Empire previously communicated that AIM Specialty Health®* (AIM) would transition the clinical criteria for medical necessity review of certain rehabilitative…
CPT 90853, the billing code for group psychotherapy sessions, has become increasingly prevalent in mental health practice as providers seek…
The Medicaid Managed Care (MMC) benefit package was modified to remove service limits on physical therapy (PT), occupational therapy (OT),…